DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174018

Comparative efficacy of visual inspection with acetic acid versus cytology for cervical cancer screening in Ogbomoso, Nigeria

Afolabi B. Abiodun, Aadewunmi O. Durodola, Mustapha A. Ajani, Isaac O. Amole, Adejoke D. Abiodun, Timothy A. O. Oluwasola

Abstract


Background: Screening test for cervical cancer using visual inspection with acetic acid (VIA) has been advocated by World Health Organization as a suitable, low cost and feasible alternative modality for control of cervical cancer in resource-poor settings as compared to cytological and colposcopic screening. The need for reproducibility, accuracy and comparable efficacy will influence the acceptability of VIA as primary screening modalities for cervical cancer.

Methods: A cross–sectional comparative study conducted at BUTH. Data were obtained from 318 consenting women aged 30–65 years using a systematic random sampling method and an interviewer–administered structured questionnaire. Pap smear samples were taken followed by visual inspection with acetic acid. Using Statistical Package for Social Sciences (SPSS) version 23.0, Frequencies were obtained and Chi-square test (X2) was used to compare rates and proportions with the level of statistical significance set at less than 0.05.

Results: Positive results for premalignant cervical lesion was 1.3% and 4.1% for VIA and Pap smear respectively (X2=4.52; p=0.034). The sensitivity of VIA was 7.7% with positive predictive value of 25% while specificity was 99.0% with a negative predictive value of 96.2%. The prevalence of abnormal cervical lesion in the population studied was 4.1% (95% CI 2.2% – 6.9%).

Conclusions: The detection rate for pre-cancerous lesions of the cervix using VIA was significantly lower than that of Pap smear in this study. There may be needed to exercise caution in adopting VIA as primary screening modality for cervical cancer.


Keywords


Cervical cancer, Cytology, Ogbomoso, Pap smear, VIA, Visual inspection

Full Text:

PDF

References


National Cancer Intelligence Network (NCIN). Cervical cancer screening. NCIN Report. 2013;9-10.

WHO. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2006 p. 123–4.

Dim CC. Towards improving cervical cancer screening in Nigeria: A review of the basics of cervical neoplasm and cytology. Nigerian Journal of Clinical Practice. 2012. p. 247-52.

Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008;109(2):22 -30.

Ogun G, Bejide R. “Cervical Cancer in Nigeria, Still a Dismal Story: the Poor State of Cervical Cytology Screening. UICC World Cancer Congress. Washington DC, USA; 2006. p. 50-4.

Ajenifuja KO, Gage JC, Adepiti AC, Wentzensen N, Eklund C, Reilly M, et al. A Population-Based Study of Acetic Acid (VIA) for Cervical Screening in Rural Nigeria. Int J Gynecol Cancer. 2013;23(3):507-12.

World Health Organization (WHO). Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. Nigeria: WHO; 2012 p. 1-33.

Sritipsukho P, Thaweekul Y. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. J Med Assoc Thai. 2010;93(7):254-61.

Albert SO, Oguntayo OA, Samaila MOA. Comparative study of visual inspection of the cervix using acetic acid (VIA) and Papanicolaou (Pap) smears for cervical cancer screening. Access. 2012;6(262):1-8.

Dianne M, Clement AO, Mirabal Y, Guillaud M, Oyedunni SA, Oladepo O, et al. Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria. Gynecol Oncol. 2007;107(1):196-207.

Adewole IF, Benedet JL, Crain BT, Follen M. Evolving a strategic approach to cervical cancer control in Africa. Gynecol Oncol. 2005;99(3):209-12.

Abimbola O. cervical cancer and its control in Nigeria: challenges and the way forward. KIT (Royal Tropical Institude) Development, Policy and Practice/Vrije Universiteit Amsterdamm; 2008. p. 1-64.

Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41-9.

Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.

De Freitas AC, Gurgel APAD, Chagas BS, Coimbra EC, Do Amaral CMM. Susceptibility to cervical cancer: An overview. Gynecologic Oncology. 2012. p. 304-11.

Sankaranarayanan R, Shastri SS, Basu P, Mahé C, Mandal R, Amin G, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev. 2004;28(5):345-51.

Awodele O, Adeyomoye A, Awodele DF, Kwashi V, Awodele IO, Dolapo DC. A study on cervical cancer screening amongst nurses in Lagos University Teaching Hospital, Lagos, Nigeria. J Cancer Educ. 2011;26(3):497-504.

Akinwuntan AL, Adesina OA, Okolo CA, Oluwasola OA, Oladokun A, Ifemeje AA, et al. Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women. J Obstet Gynecol. 2008;28(6):638-41.

Balogun MR, Odukoya OO, Oyediran M a, Ujomu PI. Cervical cancer awareness and preventive practices: a challenge for female urban slum dwellers in Lagos, Nigeria. Afr J Reprod Health. 2012;16:75-82.

WHO. Cervical Cancer Screening in Developing Countries. 2002 p. 13-36.

Bruni L, Barrionuevo-Rosas L, Serrano B, Brotons M, Albero G, Cosano R, et al. Human Papillomavirus and Related Diseases in the World. Summary Report. 2014 p. 1-146.

Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A, et al. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology. J Obstet Gynecol. 2007;27(7):703-5.

Abdel-Hady E-S, Emam M, Al-Gohary A, Hassan M, Farag MK, Abo-Elkheir M. Screening for cervical carcinoma using visual inspection with acetic acid. Int J Gynecol Obstet. 2006;93(2):118-22.

Sadan O, Schejter E, Ginath S, Bachar R, Boaz M, Menczer J, et al. Premalignant lesions of the uterine cervix in enlarge cohort of Israeli Jewish women. Arch Gynecol Obs. 2004;269(3):188-91.

Swende T, Jogo A, Ageda B. Prevalence of Cervical Intraepithelial neoplasia among seronegative women in Markudi, Nigeria. Trop J Obs Gynecol. 2010;27(1):19-22.

Ahmed S, Avidimine S, Abu T, Oguntayo A, Sabitu K. Cervical dysplastic changes in women of reproductive age in Zaria, Northern Nigeria. Trop J Obstet Gynaecol. 2010;27(1):1-8.

Oguntayo O, Samaila M. Prevalence of cervical intraepithelial neoplasia in Zaria. Ann Afr Med. 2010;9(3):194-5.

Sherigar B, Dalal A, Durdi G, Pujar Y, Dhumale H. Cervical cancer screening by visual inspection with acetic acid - interobserver variability between nurse and physician. Asian Pacific J Cancer Prev. 2010;11(2):323-6.

Sankaranarayanan R, Wesley RS. A Practical Manual on Visual Screening for Cervical Neoplasia. Lyon: IARC Press; 2003:1-14.

Denny L. Cervical cancer in South Africa: An over- view of current status and prevention strategies. CMEN. 2010;28(2):4-15.